GSK makes strong start to 2025 with growth in sales, profits and earnings
Q1 2025 £m % AER % CER Turnover 7,516 2 4 Total operating profit 2,216 49 50 Total operating margin % 29.5% 9.2ppts 9.0ppts Total EPS 39.7p 55 56 Core…
In vitro model enables study of age-specific responses to COVID mRNA vaccines
mRNA vaccines saved lives during the COVID-19 pandemic, but older people had less of an immune response to the vaccines than did younger adults. Why? Boston Children’s researchers, led by…
mRna, MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines
The University of Texas MD Anderson Cancer Center and CureVac N.V. today announced a co-development and licensing agreement to develop novel mRNA-based cancer vaccines. The collaboration creates strong synergies between…